ZHENG Wei, KANG Jingbo, WEN Juyi, WANG Jing. Influence of recombinant human endostatin combined with cisplatinum on VEGF, EGFR and tumor markers in patients with malignant pleural effusion[J]. Journal of Clinical Medicine in Practice, 2016, (23): 32-35. DOI: 10.7619/jcmp.201623010
Citation:
|
ZHENG Wei, KANG Jingbo, WEN Juyi, WANG Jing. Influence of recombinant human endostatin combined with cisplatinum on VEGF, EGFR and tumor markers in patients with malignant pleural effusion[J]. Journal of Clinical Medicine in Practice, 2016, (23): 32-35. DOI: 10.7619/jcmp.201623010
|
ZHENG Wei, KANG Jingbo, WEN Juyi, WANG Jing. Influence of recombinant human endostatin combined with cisplatinum on VEGF, EGFR and tumor markers in patients with malignant pleural effusion[J]. Journal of Clinical Medicine in Practice, 2016, (23): 32-35. DOI: 10.7619/jcmp.201623010
Citation:
|
ZHENG Wei, KANG Jingbo, WEN Juyi, WANG Jing. Influence of recombinant human endostatin combined with cisplatinum on VEGF, EGFR and tumor markers in patients with malignant pleural effusion[J]. Journal of Clinical Medicine in Practice, 2016, (23): 32-35. DOI: 10.7619/jcmp.201623010
|